Advances in nanomedicine for the treatment of infectious diseases caused by viruses

SR Dash, CN Kundu - Biomaterials Science, 2023 - pubs.rsc.org
Viruses have a worldwide impact on healthcare and social and economic growth because
they are the largest cause of mortality due to infectious diseases. Furthermore, the long-term …

Advances in pathogenesis, progression, potential targets and targeted therapeutic strategies in SARS-CoV-2-Induced COVID-19

H Zhou, WJ Ni, W Huang, Z Wang, M Cai… - Frontiers in …, 2022 - frontiersin.org
As the new year of 2020 approaches, an acute respiratory disease quietly caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus …

Development of favipiravir loaded PLGA nanoparticles entrapped in in-situ gel for treatment of Covid-19 via nasal route

V Gattani, S Dawre - Journal of drug delivery science and technology, 2023 - Elsevier
In 2019 the emergence of SARS-COV-2 caused pandemic situation worldwide and
claimed∼ 6.4 M lives (WHO 2022). Favipiravir (FAV) is recommended as a therapy for Covid …

Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses

A Kwiatkowska, LH Granicka - Membranes, 2023 - mdpi.com
This review is conducted against the background of nanotechnology, which provides us with
a chance to effectively combat the spread of coronaviruses, and which primarily concerns …

The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2

Y Hu, L Liu, S Zhang, S Su, X Liang - ACS omega, 2024 - ACS Publications
The coronavirus disease-19 (COVID-19) pandemic has had a significant impact on human
life worldwide since 2019. Specific vaccines and antiviral agents are the most effective …

Nanoparticle approaches for the renin-angiotensin system

SD Hettiarachchi, YM Kwon, Y Omidi, RC Speth - Heliyon, 2023 - cell.com
The renin-angiotensin system (RAS) is a hormonal cascade that contributes to several
disorders: systemic hypertension, heart failure, kidney disease, and neurodegenerative …

Physicochemical characteristics and in vitro toxicity/anti-SARS-CoV-2 activity of favipiravir solid lipid nanoparticles (SLNs)

AS Tulbah, WH Lee - Pharmaceuticals, 2021 - mdpi.com
The rise of coronavirus (COVID-19) cases worldwide has driven the need to discover and
develop novel therapeutics with superior efficacy to treat this disease. This study aims to …

Targeted delivery of rifaximin using P6. 2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections

PP Arayici, I Coksu, T Ozbek, S Acar - Biomaterials Advances, 2024 - Elsevier
The emergence of antibiotic resistance makes the treatment of bacterial infections difficult
and necessitates the development of alternative strategies. Targeted drug delivery systems …

Potential application of bionanoparticles to treat severe acute respiratory syndrome coronavirus-2 infection

SK Debnath, R Srivastava - Frontiers in Nanotechnology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a contagious virus that
spreads exponentially across the world, resulting in serious viral pneumonia. Several …

PLGA and PDMS-based in situ forming implants loaded with rosuvastatin and copper-selenium nanoparticles: a promising dual-effect formulation with augmented …

A Maged, M Mabrouk, HT Nour El-Din… - Frontiers in …, 2024 - frontiersin.org
Breast cancer is among the most prevalent tumors worldwide. In this study, in-situ forming
implants (ISFIs) containing rosuvastatin calcium were prepared using three types of poly (D …